IL19 and melanoma: Having established that commercially available recombinant cytokines expressed in mouse myeloma NSO cells (IL-24) or bacteria (IL-19, -20) have no growth-modulating effect on melanoma cells, we continued to examine different sources of recombinant IL-24 for their impact on melanoma cells.